Clinical Trials Logo

Advanced Solid Tumor, Adult clinical trials

View clinical trials related to Advanced Solid Tumor, Adult.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04972110 Recruiting - Clinical trials for Advanced Solid Tumor, Adult

Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors

ATTACC
Start date: July 21, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The primary purpose of this study is to assess the safety and tolerability of niraparib or olaparib in combination with RP-3500 (camonsertib), in patients with eligible advanced solid tumors, determine the maximum tolerated dose (MTD) of RP-3500 (camonsertib) in combination with niraparib or olaparib, examine pharmacokinetics (PK) and assess anti-tumor activity.